Patent
   D962433
Priority
Jun 02 2016
Filed
Oct 23 2018
Issued
Aug 30 2022
Expiry
Aug 30 2037
Assg.orig
Entity
unknown
1
1032
n/a
The ornamental design for an implant placement guide, as shown and described.

FIG. 1 is a perspective view of a design for an implant placement guide;

FIG. 2 is a first side view of the design for the implant placement guide of FIG. 1;

FIG. 3 is a second side view of the design for the implant placement guide of FIG. 1;

FIG. 4 is a front view of the design for the implant placement guide of FIG. 1;

FIG. 5 is a back view of the design for the implant placement guide of FIG. 1;

FIG. 6 is a top view for the design for the implant placement guide of FIG. 1; and,

FIG. 7 is a bottom view for the design of the implant placement guide of FIG. 1.

The dot-dash broken lines immediately adjacent the shaded areas represent the bounds of the claimed design while all other broken lines are included for the purpose of illustrating portions of the implant placement guide; the broken lines form no part of the claimed design.

Cole, Michael R., Smith, Jay S., Whitson, Amy K.

Patent Priority Assignee Title
D985377, Nov 04 2021 Caster cover
Patent Priority Assignee Title
1655158,
2110208,
2168437,
2643653,
3016895,
3025991,
3122162,
3523906,
3538916,
3620216,
3625214,
3632768,
3669104,
3691090,
3732865,
3737337,
3766915,
3773919,
3797492,
3869549,
3891570,
3960757, Jun 29 1973 Toyo Jozo Co., Ltd. Process for encapsulation of medicaments
3987790, Oct 01 1975 ALZA Corporation Osmotically driven fluid dispenser
3995631, Jan 13 1971 ALZA Corporation Osmotic dispenser with means for dispensing active agent responsive to osmotic gradient
3995632, Jan 13 1971 ALZA Corporation Osmotic dispenser
4008719, Feb 02 1976 ALZA Corporation Osmotic system having laminar arrangement for programming delivery of active agent
4034756, Jan 13 1971 ALZA Corporation Osmotically driven fluid dispenser
4078060, May 10 1976 Richardson-Merrell Inc. Method of inducing an estrogenic response
4105030, Jan 03 1977 American Home Products Corporation Implant apparatus
4111201, Nov 22 1976 ALZA Corporation Osmotic system for delivering selected beneficial agents having varying degrees of solubility
4111202, Nov 22 1976 ALZA Corporation Osmotic system for the controlled and delivery of agent over time
4111203, Nov 22 1976 ALZA Corporation Osmotic system with means for improving delivery kinetics of system
4203439, Nov 22 1976 ALZA Corporation Osmotic system with volume amplifier for increasing amount of agent delivered therefrom
4211771, Jun 01 1971 VIRATEK INC , COVINA, C A DE CORP Treatment of human viral diseases with 1-B-D-ribofuranosyl-1,2,4-triazole-3-carboxamide
4221882, Jan 31 1979 Exxon Research & Engineering Co. High impact melt-flowable dual continuum melt mixed polymer blends of polypropylene, polyethylene, and ethylene-propylene rubber
4223674, Jun 29 1978 Arthur J., McIntosh Implant gun
4243030, Aug 18 1978 Massachusetts Institute of Technology Implantable programmed microinfusion apparatus
4305927, Apr 08 1976 ALZA Corporation Method for the management of intraocular pressure
4310516, Feb 01 1980 SCHWARZ PHARMA, INC Cosmetic and pharmaceutical vehicle thickened with solid emulsifier
4340054, Dec 29 1980 ALZA Corporation Dispenser for delivering fluids and solids
4350271, Aug 22 1980 ALZA CORPORATION, Water absorbing fluid dispenser
4373527, Apr 27 1979 The Johns Hopkins University Implantable, programmable medication infusion system
4376118, Oct 06 1980 Miles Laboratories, Inc. Stable nonaqueous solution of tetracycline salt
4384975, Jun 13 1980 Sandoz, Inc. Process for preparation of microspheres
4389330, Oct 06 1980 ALKERMES CONTROLLED THERAPEUTICS INC II Microencapsulation process
4439196, Mar 18 1982 Merck & Co., Inc. Osmotic drug delivery system
4451253, Dec 18 1980 ENDOCON, INC , A CORP OF MD Means and method for administering medicinals
4455143, Mar 22 1982 ALZA Corporation Osmotic device for dispensing two different medications
4455145, Jul 10 1981 ALZA Corporation Dispensing device with internal drive
4474572, Sep 29 1981 American Home Products Corporation Implanting device and implant magazine
4530840, Jul 29 1982 ALKERMES CONTROLLED THERAPEUTICS INC II Injectable, long-acting microparticle formulation for the delivery of anti-inflammatory agents
4552561, Dec 23 1982 ALZA Corporation Body mounted pump housing and pump assembly employing the same
4588614, Oct 20 1981 Adnovum AG Pseudoplastic gel transfer
4594108, Sep 19 1983 The Dow Chemical Company Highly pseudoplastic polymer solutions
4597753, Apr 21 1983 ROUSSEL-UCLAF S A , A COMPANY OF FRANCE Implanting method and device
4609374, Apr 22 1985 ALZA Corporation Osmotic device comprising means for governing initial time of agent release therefrom
4639244, May 03 1983 ROBINSON, JOHN D , DR , 1830 FOXCROFT LANE, ALLISON PARK, PA 15101 Implantable electrophoretic pump for ionic drugs and associated methods
4655462, Jan 07 1985 BAL SEAL ENGINEERING COMPANY, INC Canted coiled spring and seal
4673405, Mar 04 1983 ALZA Corporation Osmotic system with instant drug availability
4675184, Nov 28 1981 501 Sunstar Kabushiki Kaisha; 502 Toray Industries, Inc. Pharmaceutical composition containing interferon in stable state
4695623, Apr 15 1983 AMGEN INC , A DELAWARE CORPORATION Consensus human leukocyte interferon
4727138, Jun 20 1985 Genentech, Inc. Human immune interferon
4734284, Feb 19 1985 Nippon Kayaku Kabushiki Kaisha Etoposide preparations
4743449, Sep 12 1983 Fujisawa Pharmaceutical Co., Ltd. Drug-containing lipid vesicle preparation and method for preparing them
4753651, Aug 30 1982 ALZA CORPORATION A CORP OF CA Self-driven pump
4762791, Oct 19 1981 Genentech, Inc. Human immune interferon
4765989, May 11 1983 ALZA CORPORATION, A CORP OF DE Osmotic device for administering certain drugs
4783337, May 11 1983 ALZA Corporation Osmotic system comprising plurality of members for dispensing drug
4787437, Mar 14 1986 Stopinc Aktiengesellschaft Method for starting a continuous casting plant
4818517, Jan 24 1986 N V ORGANON Pharmaceutical preparation for obtaining a highly viscose hydrogel or suspension
4820267, Feb 19 1985 ENDOCON, INC , A CORP OF MD Cartridge injector for pellet medicaments
4820638, May 28 1982 DR KARL THOMAE GMBH Novel alpha interferon species produced by recombinant means
4826144, Apr 25 1988 BAL SEAL ENGINEERING COMPANY, INC Inside back angle canted coil spring
4830344, Apr 25 1988 BAL SEAL ENGINEERING COMPANY, INC Canted-coil spring with turn angle and seal
4834708, Mar 31 1987 Merit Medical Systems, Inc Puncture needle assembly
4840896, Nov 02 1983 Genzyme Corporation Heteropolymeric protein
4845196, Jun 24 1985 G D SEARLE AND CO , 1751 LAKE COOK RD , DEERFIELD, IL 60015 A CORP OF DE Modified interferon gammas
4847079, Jul 29 1985 Schering Corporation Biologically stable interferon compositions comprising thimerosal
4851228, Jun 20 1984 MERCK & CO , INC , A CORP OF NJ Multiparticulate controlled porosity osmotic
4865845, Mar 21 1986 ALZA Corporation Release rate adjustment of osmotic or diffusional delivery devices
4871094, Dec 31 1986 ALCON MANUFACTURING, LTD Means and method for dispensing substances
4873080, Jun 08 1983 Dr. Karl Thomae GmbH Oral anti-diabetic pharmaceutical compositions and the preparation thereof
4874388, Jun 25 1987 ALZA Corporation Multi-layer delivery system
4876781, Apr 25 1988 BAL SEAL ENGINEERING COMPANY, INC Method of making a garter-type axially resilient coiled spring
4882166, Sep 30 1981 British Technology Group Limited Compositions comprising encapsulated particles and their preparation
4885166, Jun 11 1985 Novartis Corporation Hybrid interferons
4886668, Sep 24 1987 Merck & Co., Inc. Multiparticulate controlled porosity osmotic pump
4892778, May 27 1987 ALZA Corporation Juxtaposed laminated arrangement
4893795, Aug 15 1988 BAL SEAL ENGINEERING COMPANY, INC Radially loaded canted coiled spring with turn angle
4897471, Apr 15 1983 AMGEN INC , A DELAWARE CORPORATION Consensus human leukocyte interferon
4907788, Apr 25 1988 BAL SEAL ENGINEERING COMPANY, INC Dual concentric canted-coil spring apparatus
4915366, Apr 25 1988 BAL SEAL ENGINEERING COMPANY, INC Outside back angle canted coil spring
4915949, Jul 13 1987 ALZA Corporation Dispenser with movable matrix comprising a plurality of tiny pills
4915954, Sep 03 1987 ALZA Corporation Dosage form for delivering a drug at two different rates
4917887, Mar 10 1986 Boehringer Ingelheim International GmbH Hybrid interferons, their use as pharmaceutical compositions and as intermediate products for the preparation of antibodies and the use thereof and processes for preparing them
4917895, Nov 02 1987 ALZA Corporation Transdermal drug delivery device
4923805, Nov 02 1983 Genzyme Corporation FSH
4927687, Oct 01 1984 BIOTEK, Inc. Sustained release transdermal drug delivery composition
4929554, Oct 19 1981 Human immune interferon
4931285, Apr 28 1988 ALZA Corporation Aqueous based pharmaceutical coating composition for dosage forms
4934666, Apr 25 1988 BAL SEAL ENGINEERING COMPANY, INC Coiled spring electromagnetic shielding gasket
4940465, May 27 1987 Dispenser comprising displaceable matrix with solid state properties
4940588, Oct 30 1984 Elan Pharma International Limited Controlled release powder and process for its preparation
4952402, Oct 30 1984 Elan Pharma International Limited Controlled release powder and process for its preparation
4957119, Aug 08 1987 ORGANON USA INC Contraceptive implant
4961253, Apr 25 1988 BAL SEAL ENGINEERING COMPANY, INC Manufacturing method for canted-coil spring with turn angle and seal
4964204, Apr 25 1988 BAL SEAL ENGINEERING COMPANY, INC Method for making a garter-type axially-resilient coil spring
4969884, Dec 28 1988 ALZA Corporation Osmotically driven syringe
4974821, Apr 25 1988 BAL SEAL ENGINEERING COMPANY, INC Canted-coil spring with major axis radial loading
4976966, Dec 29 1988 ALZA Corporation Delayed release osmotically driven fluid dispenser
4994028, Mar 18 1987 Endocon, Inc. Injector for inplanting multiple pellet medicaments
5004689, Feb 22 1982 BIOGEN, INC , A CORP OF MA DNA sequences, recombinant DNA molecules and processes for producing human gamma interferon-like polypeptides in high yields
5006346, Apr 28 1988 ALZA Corporation Delivery system
5019382, Nov 06 1986 The Texas A&M University System Treatment of immuno-resistant disease with low-dose interferon
5019400, May 01 1989 ALKERMES CONTROLLED THERAPEUTICS, INC Very low temperature casting of controlled release microspheres
5023088, Jun 25 1987 ALZA Corporation; ALZA CORPORATION, A CORP OF DE Multi-unit delivery system
5024842, Apr 28 1988 ALZA Corporation Annealed coats
5030216, Dec 15 1989 ALZA Corporation Osmotically driven syringe
5034229, Dec 13 1988 ALZA Corporation Dispenser for increasing feed conversion of hog
5053014, Feb 01 1990 MEDEX, INC Catheter with controlled valve
5057318, Dec 13 1988 ALZA Corporation Delivery system for beneficial agent over a broad range of rates
5059423, Dec 13 1988 ALZA Corporation Delivery system comprising biocompatible beneficial agent formulation
5066436, Jan 04 1989 BROCADES PHARMA B V , A CORPORATION OF THE NETHERLANDS Process for microencapsulation
5071642, Oct 23 1986 DR RENTSCHLER GMBH & CO MEDIZIN KG Dihydropyridine containing compositions
5072070, Dec 01 1989 BAL SEAL ENGINEERING COMPANY, INC Device for sealing electromagnetic waves
5079388, Dec 01 1989 BAL SEAL ENGINEERING COMPANY, INC Gasket for sealing electromagnetic waves
5090962, Apr 28 1989 LOKSHOT SA Non-reusable syringe
5091188, Apr 26 1990 PAUL ROYALTY FUND, L P Phospholipid-coated microcrystals: injectable formulations of water-insoluble drugs
5108078, Apr 25 1988 BAL SEAL ENGINEERING COMPANY, INC Canted-coil spring loaded while in a cavity
5110596, Dec 13 1988 ALZA Corporation Delivery system comprising means for delivering agent to livestock
5112614, Sep 14 1989 ALZA Corporation Implantable delivery dispenser
5113938, May 07 1991 Whipstock
5117066, Apr 25 1988 BAL SEAL ENGINEERING COMPANY, INC Retaining and locking electromagnetic gasket
5118666, May 05 1986 The General Hospital Corporation Insulinotropic hormone
5120306, Mar 21 1990 Direct delivery of anti-inflammatories to the proximal small bowel
5120712, May 05 1986 The General Hospital Corporation Insulinotropic hormone
5120832, Aug 27 1984 Genentech, Inc. Distinct family of human leukocyte interferons
5122128, Mar 15 1990 ALZA CORPORATION A CORP OF DELAWARE Orifice insert for a ruminal bolus
5122377, Nov 19 1990 Wyeth Oral delivery system for veterinary drugs
5126142, Jul 18 1989 ALZA Corporation Dispenser comprising ionophore
5128147, Jan 06 1989 Thermal Developments, Inc. Heat intensifier and localizer for radiofrequency thermotherapy
5134244, Apr 25 1988 BAL SEAL ENGINEERING COMPANY, INC Electromagnetic shielding seal for rotary/reciprocating shaft
5137727, Jun 12 1991 ALZA Corporation Delivery device providing beneficial agent stability
5147295, Jan 23 1991 NEOGEN CORPORATION Retractable implanter
5151093, Oct 29 1990 DURECT CORPORATION Osmotically driven syringe with programmable agent delivery
5160122, Mar 20 1990 BAL SEAL ENGINEERING COMPANY, INC Coil spring with an elastomer having a hollow coil cross section
5160743, Apr 28 1988 ALZA Corporation Annealed composition for pharmaceutically acceptable drug
5161806, Dec 17 1990 BAL SEAL ENGINEERING COMPANY, INC Spring-loaded, hollow, elliptical ring seal
5180591, Jul 11 1990 ALZA Corporation Delivery device with a protective sleeve
5190765, Jun 27 1991 ALZA Corporation Therapy delayed
5192273, Jul 24 1989 VENETEC INTERNATIONAL, INC Catheterization system
5203849, Mar 20 1990 BAL SEAL ENGINEERING COMPANY, INC Canted coil spring in length filled with an elastomer
5204108, Oct 10 1987 West Pharmaceutical Services Drug Delivery & Clinical Research Centre Limited Transmucosal formulations of low molecular weight peptide drugs
5207752, Mar 30 1990 ALZA CORPORATION, A CORPORATION OF DE Iontophoretic drug delivery system with two-stage delivery profile
5209746, Feb 18 1992 ALZA Corporation Osmotically driven delivery devices with pulsatile effect
5213809, Jan 24 1990 ALZA Corporation Delivery system comprising means for controlling internal pressure
5213810, Mar 30 1990 American Cyanamid Company Stable compositions for parenteral administration and method of making same
5219572, Mar 17 1989 Schering-Plough Animal Health Corporation Controlled release delivery device for macromolecular proteins
5221278, Mar 12 1992 ALZA Corporation Osmotically driven delivery device with expandable orifice for pulsatile delivery effect
5223265, Jan 10 1992 ALZA Corporation; ALZA CORPORATION A CORPORATION OF DE Osmotic device with delayed activation of drug delivery
5225205, Jul 28 1989 Debio Recherche Pharmaceutique SA Pharmaceutical composition in the form of microparticles
5231176, Aug 27 1984 Genentech, Inc. Distinct family DNA encoding of human leukocyte interferons
5234424, Dec 28 1988 ALZA Corporation Osmotically driven syringe
5234692, Jul 11 1990 ALZA Corporation Delivery device with a protective sleeve
5234693, Jul 11 1990 ALZA Corporation Delivery device with a protective sleeve
5234695, Jul 24 1990 Eastman Chemical Company Water dispersible vitamin E composition
5250026, May 27 1992 Digital Angel Corporation Adjustable precision transponder injector
5252338, Jun 27 1991 ALZA Corporation Therapy delayed
5260069, Nov 27 1992 BANK OF AMERICA, N A , AS AGENT Pulsatile particles drug delivery system
5278151, Apr 02 1987 Ocular Research of Boston, Inc. Dry eye treatment solution
5279544, Mar 13 1992 Elan Pharma International Limited Transdermal or interdermal drug delivery devices
5279554, Feb 09 1990 Merial Implanting device
5279555, Aug 24 1992 Merck & Co., Inc.; MERCK & CO , INC Device for injecting implants
5279608, Dec 18 1990 Societe de Conseils de Recherches et d'Applications Scientifiques Osmotic pumps
5284655, Aug 27 1990 Warsaw Orthopedic, Inc Swollen demineralized bone particles, flowable osteogenic composition containing same and use of the composition in the repair of osseous defects
5288501, Jul 04 1991 MERZ PHARMA GMBH & CO KGAA Mechanically-stable, readily-disintegratable tablets made of small preformed particles containing active ingredients
5288502, Oct 16 1991 Board of Regents, The University of Texas System Preparation and uses of multi-phase microspheres
5290271, May 14 1990 DERMAGENESIS, LLC Surgical implant and method for controlled release of chemotherapeutic agents
5300079, Jan 30 1991 Texas Instruments Incorporated Injector
5300302, Oct 04 1990 Nestec S.A. Pharmaceutical composition in gel form in a dispensing package
5308348, Feb 18 1992 ALZA Corporation Delivery devices with pulsatile effect
5312335, Nov 09 1989 BIOJECT INC , AN OR CORP Needleless hypodermic injection device
5312389, Oct 29 1990 DURECT CORPORATION Osmotically driven syringe with programmable agent delivery
5312390, Jan 10 1992 ALZA Corporation Osmotic device with delayed activation of drug delivery
5318558, Mar 12 1992 ALZA Corporation Osmotically driven delivery device with expandable orifice for pulsatile delivery effect
5318780, Oct 30 1991 MDV TECHNOLOGIES, INC Medical uses of in situ formed gels
5320616, Dec 13 1988 ALZA Corporation Delivery system comprising first walled section and second walled section united by fusion, adhesion or telescopic engagement
5324280, Apr 02 1990 ALZA Corporation Osmotic dosage system for delivering a formulation comprising liquid carrier and drug
5336057, Sep 30 1991 Nippon Densan Corporation Micropump with liquid-absorptive polymer gel actuator
5336505, Aug 28 1989 PHARMACEUTICAL DELIVERY SYSTEM Bioerodible polymers useful for the controlled release of therapeutic agents
5348544, Nov 24 1993 Becton, Dickinson and Company Single-handedly actuatable safety shield for needles
5352662, Oct 01 1991 Eli Lilly and Company Injectable extended release formulations and methods
5368588, Feb 26 1993 Parenteral fluid medication reservoir pump
5368863, Jan 24 1990 ALZA Corporation Long-term delivery device with early startup
5371089, Feb 26 1987 Senetek, PLC Method and composition for ameliorating the adverse effects of aging
5374620, Jun 07 1990 Genentech, Inc Growth-promoting composition and its use
5385738, Oct 14 1983 Sumitomo Pharmaceuticals Company, Ltd. Sustained-release injection
5385887, Sep 10 1993 Genetics Institute, LLC Formulations for delivery of osteogenic proteins
5395319, Mar 06 1991 Suddeutsche Feinmechanik GmbH Needle for inserting an object into the body
5407609, May 04 1989 BROOKWOOD PHARMACEUTICALS, INC Microencapsulation process and products therefrom
5411951, Oct 04 1984 Eli Lilly and Company Prolonged release of biologically active somatotropin
5413572, Apr 02 1990 ALZA Corporation Osmotic dosage system for liquid drug delivery
5413672, Jul 22 1992 MFM TECHNOLOGY, L L C Method of etching sendust and method of pattern-etching sendust and chromium films
5424286, May 24 1993 Exendin-3 and exendin-4 polypeptides, and pharmaceutical compositions comprising same
5428024, Feb 28 1992 Allergan, Inc High concentration homogenized collagen compositions
5429602, Apr 29 1992 Programmable portable infusion pump system
5439688, Jul 20 1990 DEBIO RECHERCHE PHARMACEUTIQUE S A Process for preparing a pharmaceutical composition
5443459, Jan 30 1991 ALZA Corporation Osmotic device for delayed delivery of agent
5445829, May 05 1989 Drugtech Corporation Extended release pharmaceutical formulations
5456679, Feb 18 1992 ALZA Corporation Delivery devices with pulsatile effect
5458888, Mar 02 1994 BANK OF AMERICA, N A , AS AGENT Controlled release tablet formulation
5464929, Mar 06 1995 Ethicon, Inc. Absorbable polyoxaesters
5472708, Nov 27 1992 BANK OF AMERICA, N A , AS AGENT Pulsatile particles drug delivery system
5478564, Feb 22 1990 Teva Pharmaceutical Industries Ltd Preparation of microparticles for controlled release of water-soluble substances
5484403, Apr 05 1994 AVID IDENTIFICATION SYSTEMS, INC Hypodermic syringe for implanting solid objects
5486365, Sep 17 1993 DOW CORNING ENTERPRISES, INC AS COLLATERAL AGENT Calcium hydrogen phosphate, a method for preparing it, and an excipient utilizing it
5498255, Aug 17 1993 ALZA Corporation Osmotic device for protracted pulsatile delivery of agent
5511355, Apr 06 1992 Construction element
5512293, Jul 23 1992 ALZA Corporation Oral sustained release drug delivery device
5512549, Oct 18 1994 Eli Lilly and Company Glucagon-like insulinotropic peptide analogs, compositions, and methods of use
5514110, Mar 22 1993 Automatic flow control device
5529914, Aug 05 1991 BOARD OF REGENTS, THE Gels for encapsulation of biological materials
5531736, Jan 30 1991 ALZA Corporation Osmotic device for delayed delivery of agent
5540665, Jan 31 1994 ALZA Corporation Gas driven dispensing device and gas generating engine therefor
5540912, Mar 30 1993 ALZA Corporation Viscous suspensions of controlled-release drug particles
5541172, Jun 28 1991 Endorecherche, Inc. Controlled release systems and low dose androgens
5542682, Mar 27 1995 TI SPECIALTY POLYMER PRODUCTS, INC Slant coil spring and seal
5543156, Jan 09 1991 ALZA Corporation Bioerodible devices and compositions for diffusional release of agents
5545618, Sep 20 1991 SCIOS, INC GLP-1 analogs useful for diabetes treatment
5556642, Jul 16 1992 Tanabe Seiyaku Co., Ltd. Method for producing sustained release microsphere preparation
5557318, Jul 12 1994 Koninklijke PTT Nederland N.V. Method and apparatus for permitting a viewer to scan through a plurality of video signals provided by a transmitter
5558637, Oct 13 1993 Leiras Oy Implant injection device
5569289, Jun 24 1993 Safety penetrating instrument with penetrating member and cannula moving during penetration and triggered safety member protusion
5571525, Mar 30 1993 DURECT CORPORATION Erosion rate modifier for use in bioerodible drug delivery devices and method of use
5574008, Aug 30 1994 Eli Lilly and Company Biologically active fragments of glucagon-like insulinotropic peptide
5574137, Dec 16 1983 Genentech, Inc. Recombinant gamma interferons having enhanced stability and methods therefor
5580578, Jan 27 1992 Purdue Pharma LP Controlled release formulations coated with aqueous dispersions of acrylic polymers
5589167, Feb 23 1993 Genentech, Inc. Excipient stabilization of polypeptides treated with organic solvents
5595751, Mar 06 1995 Ethicon, Inc.; Ethicon, Inc Absorbable polyoxaesters containing amines and/or amido groups
5595759, Nov 10 1994 ALZA Corporation Process for providing therapeutic composition
5597579, Mar 06 1995 Ethicon, Inc.; Ethicon, Inc Blends of absorbable polyoxaamides
5602010, Dec 10 1986 Boehringer Ingelheim International GmbH DNA encoding equine-gamma interferon and recombinant production of equine IFN-γ polypeptides
5605688, Aug 16 1985 Boehringer Ingelheim International GmbH Recombinant dog and horse type I interferons
5607687, Mar 06 1995 Ethicon, Inc.; Ethicon, Inc Polymer blends containing absorbable polyoxaesters
5609885, Sep 15 1992 ALZA Corporation Osmotic membrane and delivery device
5613954, Nov 21 1994 Stryker Corporation Laparoscopic surgical Y-tube cannula
5614221, Oct 23 1989 Medivent Method of preparing a drug delivery system comprising a drug and a gel using a syringe
5614492, May 05 1986 The General Hospital Corporation Insulinotropic hormone GLP-1 (7-36) and uses thereof
5618552, Mar 06 1995 Ethicon, Inc.; Ethicon, Inc Absorbable polyoxaesters
5620698, Mar 06 1995 Ethicon, Inc. Blends of absorbable polyoxaesters containing amines and/or amido groups
5620705, Aug 04 1994 Encinal Pharmaceutical Investments, LLC Progestin tablet
5630796, Apr 08 1993 Powderject Research Limited Method of delivering powder transdermally with needless injector
5633011, Aug 04 1994 Encinal Pharmaceutical Investments, LLC Progesterone replacement therapy
5635213, Nov 30 1992 ABBVIE B V Pharmaceutical formulation
5639477, Jun 23 1993 ALZA Corporation Ruminal drug delivery device
5639640, Nov 02 1983 Genzyme Corporation DNA encoding the beta subunit of human follide stimulating hormone and expression vectors and cells containing same
5645850, Mar 06 1995 Ethicon, Inc. Blending containing absorbable polyoxaamides
5648088, Mar 06 1995 Ethicon, Inc.; Ethicon, Inc Blends of absorbable polyoxaesters containing amines and/or amide groups
5650173, Nov 19 1993 ALKERMES, INC Preparation of biodegradable microparticles containing a biologically active agent
5654008, Nov 19 1993 ALKERMES, INC Preparation of biodegradable microparticles containing a biologically active agent
5654010, Dec 02 1992 ALKERMES CONTROLLED THERAPEUTICS, INC Composition for sustained release of human growth hormone
5656297, Mar 12 1992 ALKERMES CONTROLLED THERAPEUTICS, INC 64 SIDNEY STREET Modulated release from biocompatible polymers
5656299, Nov 17 1992 REEDHYCALOG, L P Sustained release microsphere preparation containing antipsychotic drug and production process thereof
5658593, Jan 16 1992 Coletica Injectable compositions containing collagen microcapsules
5660847, Sep 14 1989 ALZA Corporation Implantable delivery dispenser comprising exit port
5660858, Apr 03 1996 Jagotec AG Cyclosporin emulsions
5660861, Apr 18 1994 ALZA Corporation Effective therapy for epilepsies
5667808, Dec 02 1992 ALKERMES CONTROLLED THERAPEUTICS, INC Composition for sustained release of human growth hormone
5668170, Jul 13 1994 ALZA Corporation Composition and method enhancing transdermal electrotransport agent delivery
5672549, Jan 31 1996 Sumitomo Bakelite Company Limited Method of producing epoxy resin-encapsulated semiconductor device
5676942, Feb 10 1992 HEMISPHERX BIOPHARMA, INC Composition containing human alpha interferon species proteins and method for use thereof
5686097, Sep 29 1993 ALZA Corporation Monoglyceride/lactate ester permeation enhancer for codelivery of steroids
5688801, Nov 19 1993 ALKERMES, INC Method of inhibiting neurotransmitter activity using microencapsulated 3-piperidiny2-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles
5690925, Dec 16 1983 Genentech, Inc. Recombinant gamma interferons having enhanced stability and methods therefor
5690952, Jun 07 1995 ALZA Corporation Implantable system for delivery of fluid-sensitive agents to animals
5695463, Sep 27 1994 IPSEN PHARMA S A S Safety injection device
5697914, Mar 16 1995 Becton Dickinson and Company Control forward/flashback forward one hand introducer needle and catheter assembly
5698213, Mar 06 1995 Ethicon, Inc Hydrogels of absorbable polyoxaesters
5700486, Nov 22 1990 APTALIS PHARMATECH, INC Pharmaceutical compositions in the form of particles suitable for the controlled release of pharmacologically active substances and process for preparing the same compositions
5700583, Mar 06 1995 Ethicon, Inc Hydrogels of absorbable polyoxaesters containing amines or amido groups
5703200, Mar 15 1996 Ethicon, Inc. Absorbable copolymers and blends of 6,6-dialkyl-1,4-dioxepan-2-one and its cyclic dimer
5707644, Nov 04 1989 West Pharmaceutical Services Drug Delivery & Clinical Research Centre Limited Small particle compositions for intranasal drug delivery
5711967, Jun 17 1991 Spirig AG, Pharmazeutische Praeparate Oral diclofenac preparation
5713847, Nov 01 1994 The University of Iowa Research Foundation Human drug delivery device for tinnitus
5718922, May 31 1995 Schepens Eye Research Institute, Inc. Intravitreal microsphere drug delivery and method of preparation
5725497, Jun 07 1995 American Cyanamid Company Injection dart system
5728088, Dec 13 1988 ALZA Corporation Osmotic system for delivery of fluid-sensitive somatotropins to bovine animals
5728396, Feb 02 1996 INTARCIA THERAPEUTICS, INC Sustained delivery of leuprolide using an implantable system
5733572, Dec 22 1989 IMARX THERAPEUTICS, INC Gas and gaseous precursor filled microspheres as topical and subcutaneous delivery vehicles
5736159, Apr 28 1995 BANK OF AMERICA, N A , AS AGENT Controlled release formulation for water insoluble drugs in which a passageway is formed in situ
5738845, Mar 02 1989 WOMEN S RESEARCH INSTITUTE, THE Human interferon τ proteins and methods of use
5747058, Jun 07 1995 DURECT CORPORATION High viscosity liquid controlled delivery system
5756450, Sep 15 1987 Novartis Corporation Water soluble monoesters as solubilisers for pharmacologically active compounds and pharmaceutical excipients and novel cyclosporin galenic forms
5767251, Jan 30 1985 Genzyme Corporation Recombinant heterodimeric human fertility hormones, and methods, cells, and vectors and DNA for the production thereof
5770231, Nov 19 1993 ALKERMES, INC Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles 1,2-benzisothiazoles
5782396, Aug 28 1995 Tyco Healthcare Group LP Surgical stapler
5792477, May 02 1997 ALKERMES, INC Preparation of extended shelf-life biodegradable, biocompatible microparticles containing a biologically active agent
5795591, Oct 10 1991 ALZA Corporation Osmotic drug delivery devices with hydrophobic wall materials
5795779, Nov 01 1982 Berlex Laboratories, Inc.; Leland Stanford Junior University Human interferon-β (IFN-β) produced in Chinese hamster ovary (CHO) cells
5807876, Apr 23 1996 VERTEX PHARMACEUTICALS INCORPORATED Inhibitors of IMPDH enzyme
5810769, Feb 25 1994 Suddeutsche Feinmechanik GmbH Cannula for the subcutaneous deposition of an object
5814323, Oct 16 1995 Lever Brothers Company, Division of Conopco, Inc. Cosmetic composition
5817129, Oct 31 1996 Ethicon, Inc Process and apparatus for coating surgical sutures
5827297, Oct 01 1992 Medicamat S.A. Device for transplanting small diameter hair grafts
5830501, Dec 06 1991 ALZA Corporation Dosage form comprising hydrophilic polymer
5836935, Nov 10 1994 UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE Implantable refillable controlled release device to deliver drugs directly to an internal portion of the body
5843891, Apr 28 1993 Pharmaceutical acceptable compositions containing an alcohol and a hydrophobic drug
5844017, Mar 06 1995 Ethicon, Inc Prepolymers of absorbable polyoxaesters containing amines and/or amido groups
5851451, Dec 15 1995 Takeda Pharmaceutical Company, Limited Production of microspheres
5858746, Apr 20 1992 Board of Regents, The University of Texas System Gels for encapsulation of biological materials
5859150, Mar 06 1995 Ethicon, Inc Prepolymers of absorbable polyoxaesters
5861166, Mar 12 1991 ALZA Corporation Delivery device providing beneficial agent stability
5871770, Jun 07 1995 ALZA Corporation Implantable system for delivery of fluid-sensitive agents to animals
5871778, Nov 17 1992 Mitsubishi Pharma Corporation Sustained release microsphere preparation containing antipsychotic drug
5874388, Apr 02 1997 Dow Corning Corporation Lubricant composition for disc brake caliper pin and a disc brake asembly containing the lubricant
5876746, Jun 07 1995 Ortho-McNeil Pharmaceutical, Inc Transdermal patch and method for administering 17-deacetyl norgestimate alone or in combination with an estrogen
5882676, May 26 1995 ALZA Corporation Skin permeation enhancer compositions using acyl lactylates
5904935, Jun 07 1995 INTARCIA THERAPEUTICS, INC Peptide/protein suspending formulations
5906599, Nov 09 1995 INTERMED, INC Device for delivering biological agents
5906816, Mar 16 1995 University of Florida Method for treatment of autoimmune diseases
5906830, Sep 08 1995 Ortho-McNeil Pharmaceutical, Inc Supersaturated transdermal drug delivery systems, and methods for manufacturing the same
5908621, Nov 02 1995 Merck Sharp & Dohme Corp Polyethylene glycol modified interferon therapy
5916598, May 07 1996 ALKERMES, INC Preparation of biodegradable, biocompatible microparticles containing a biologically active agent
5922253, May 18 1995 ALKERMES CONTROLLED THERAPEUTICS, INC, Production scale method of forming microparticles
5928666, Nov 12 1996 Ortho-McNeil Pharmaceutical, Inc Crystalline form of estradiol and pharmaceutical formulations comprising same
5932547, Jun 13 1997 HORATIO WASHINGTON DEPOT TECHNOLOGIES LLC Non-aqueous polar aprotic peptide formulations
5938654, Jun 25 1987 ALZA Corporation Osmotic device for delayed delivery of agent
5939286, May 10 1995 FLORIDA, UNIVERSITY OF, A FLORIDA CORPORATION Hybrid interferon tau/alpha polypeptides, their recombinant production, and methods using them
5942223, Mar 02 1989 WOMENS S RESEARCH INSTITUTE, THE Antiviral therapy using ovine or bovine interferon-tau
5942253, Oct 12 1995 ALCAFLEU MANAGEMENT GMBH & CO KG Prolonged release of GM-CSF
5945126, Feb 13 1997 OAKWOOD LABORATORIES L L C , A DELAWARE LIMITED LIABILITY CORPORATION Continuous microsphere process
5948430, Nov 11 1996 LTS Lohmann Therapie-Systeme GmbH Water soluble film for oral administration with instant wettability
5951521, Sep 25 1998 MEDTRONIC MINIMED, INC Subcutaneous implantable sensor set having the capability to remove deliver fluids to an insertion site
5958909, May 05 1986 The General Hospital Corporation Insulinotropic hormones and uses thereof
5962023, Mar 06 1995 Ethicon, Inc Hydrogels containing absorbable polyoxaamides
5965168, Nov 19 1993 ALKERMES, INC Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles
5972370, Jun 07 1995 INTARCIA THERAPEUTICS, INC Peptide/protein suspending formulations
5972373, May 02 1995 Taisho Pharmaceutical Co., Ltd. Taste masking pharmaceutical composition for oral administration
5976109, Apr 30 1996 Medtronic, Inc Apparatus for drug infusion implanted within a living body
5980945, Jan 16 1996 IPSEN PHARMA S A S Sustained release drug formulations
5981719, Mar 09 1993 Baxter International Inc; BAXTER HEALTHCARE SA A CORPORATION OF SWITZERLAND Macromolecular microparticles and methods of production and use
5984890, Sep 27 1996 Wyeth Medical device for the placement of solid materials
5985305, Feb 02 1996 INTARCIA THERAPEUTICS, INC Sustained delivery of an active agent using an implantable system
5989463, Sep 24 1997 ALKERMES CONTROLLED THERAPEUTICS, INC Methods for fabricating polymer-based controlled release devices
5997527, Mar 24 1997 INTARCIA THERAPEUTICS, INC Self adjustable exit port
5997902, Jun 23 1993 ALZA Corporation Ruminal drug delivery device
6007805, Mar 07 1994 Imperial College of Science and Technology Use of interferon subtype alpha-8 (IFN-α8) to treat viral infections of the liver
6017545, Feb 10 1998 GENEREX PHARMACEUTICALS INC Mixed micellar delivery system and method of preparation
6022561, Feb 04 1994 LIPOCORE HOLDING AB Bilayers preparations
6029361, Mar 25 1998 ULTRATECH, INC Air-guage nozzle probe structure for microlithographic image focusing
6053927, Oct 15 1998 RSH-GS Trust Apparatus and method for implant removal
6056718, Mar 04 1998 MEDTRONIC MINIMED, INC Medication infusion set
6060450, Mar 16 1995 University of Florida Method for treatment of autoimmune diseases
6069133, Mar 14 1996 IMMUNE RESPONSE CORPORATION, THE Targeted delivery of genes encoding interferon
6074377, Oct 10 1996 Method of installing vascular access device
6074660, Apr 20 1998 Ethicon, Inc Absorbable polyoxaesters containing amines and/ or amido groups
6074673, Apr 22 1996 Slow-release, self-absorbing, drug delivery system
6100346, Mar 06 1995 Ethicon, Inc Copolymers of polyoxaamides
6110503, May 07 1996 ALKERMES, INC Preparation of biodegradable, biocompatible microparticles containing a biologically active agent
6113938, Dec 30 1997 INTARCIA THERAPEUTICS, INC Beneficial agent delivery system with membrane plug and method for controlling delivery of beneficial agents
6113947, Jun 13 1997 Genentech, Inc Controlled release microencapsulated NGF formulation
6120787, Oct 19 1995 PACIRA PHARMACEUTICALS, INC Sustained release particles
6124261, Jun 13 1997 HORATIO WASHINGTON DEPOT TECHNOLOGIES LLC Non-aqueous polar aprotic peptide formulations
6124281, Mar 08 1996 AstraZeneca UK Limited Azolobenzazepine derivatives as neurologically active agents
6127520, Apr 15 1997 REGENTS OF THE UNIVERSITY OF MICHIGAN, THE Compositions and methods for the inhibition of neurotransmitter uptake of synaptic vesicles
6129761, Jun 07 1995 REPROGENESIS, INC Injectable hydrogel compositions
6130200, Dec 20 1996 DURECT CORPORATION Gel composition and methods
6132420, Feb 02 1996 INTARCIA THERAPEUTICS, INC Osmotic delivery system and method for enhancing start-up and performance of osmotic delivery systems
6133249, Dec 19 1995 MacNaught Medical Pty Limited Phospholipid and propylene glycol based lubricant
6133429, Oct 03 1997 Becton Dickinson and Company Chromophores useful for the preparation of novel tandem conjugates
6146139, Jun 01 1999 Forceps apparatus
6147168, Mar 06 1995 Ethicon, Inc. Copolymers of absorbable polyoxaesters
6156331, Feb 02 1996 INTARCIA THERAPEUTICS, INC Sustained delivery of an active agent using an implantable system
6172046, Sep 21 1997 Merck Sharp & Dohme Corp Combination therapy for eradicating detectable HCV-RNA in patients having chronic Hepatitis C infection
6174547, Sep 09 1998 Encinal Pharmaceutical Investments, LLC Dosage form comprising liquid formulation
6177096, Nov 11 1996 LTS Lohmann Therapie-Systeme AG Water soluble film for oral administration with instant wettability
6183461, Mar 11 1998 SOLACE THERAPEUTICS, INC Method for delivering a medication
6187095, Oct 31 1996 Process and apparatus for coating surgical sutures
6190350, Dec 29 1997 INTARCIA THERAPEUTICS, INC Implanter device for subcutaneous implants
6190700, Dec 15 1995 Takeda Pharmaceutical Company, Limited Production of sustained-release preparation for injection
6190702, Mar 28 1996 Takeda Pharmaceutical Company, Limited Sustained-released material prepared by dispersing a lyophilized polypeptide in an oil phase
6191102, Nov 05 1996 Eli Lilly and Company Use of GLP-1 analogs and derivatives administered peripherally in regulation of obesity
6204022, Apr 12 1996 University of Florida Research Foundation, Incorporated Low-toxicity human interferon-alpha analogs
6217893, Apr 18 1997 Ipsen Pharma Biotech Sustained-release compositions and method for preparing same
6217906, Mar 24 1997 INTARCIA THERAPEUTICS, INC Self adjustable exit port
6217908, Apr 24 1992 PEROSPHERE INC Bioadhesive microspheres and their use as drug delivery and imaging systems
6218431, Jul 31 1997 Bayer Pharmaceuticals Corporation Substituted biphenyls
6224894, Mar 06 1995 Ethicon, Inc. Copolymers of absorbable polyoxaesters
6235712, Jun 13 1997 HORATIO WASHINGTON DEPOT TECHNOLOGIES LLC Non-aqueous polar aprotic peptide formulations
6245349, Feb 23 1996 ATHENA NEUROSCIENCES, INC Drug delivery compositions suitable for intravenous injection
6245357, Mar 06 1998 ALZA Corporation Extended release dosage form
6248112, Sep 30 1998 C R BARD, INC Implant delivery system
6251435, Mar 06 1995 Ethicon, Inc. Hydrogels containing absorbable polyoxaamides
6258377, Jul 02 1996 Provalis UK Limited Hydrophobic preparations containing medium chain monoglycerides
6261584, Feb 02 1996 INTARCIA THERAPEUTICS, INC Sustained delivery of an active agent using an implantable system
6268343, Aug 30 1996 Novo Nordisk A S Derivatives of GLP-1 analogs
6270700, Jul 23 1998 IPSEN PHARMA S A S Encapsulation of water soluble peptides
6270787, Dec 29 1997 INTARCIA THERAPEUTICS, INC Osmotic delivery system with membrane plug retention mechanism
6277413, Jul 17 1998 PACIRA PHARMACEUTICALS, INC Biodegradable compositions for the controlled release of encapsulated substances
6283949, Dec 27 1999 Advanced Cardiovascular Systems, INC Refillable implantable drug delivery pump
6284264, Nov 11 1996 LTS Lohmann Therapie-Systeme GmbH Water soluble film for oral administration with instant wettability
6284725, Oct 08 1998 AstraZeneca Pharmaceuticals LP Metabolic intervention with GLP-1 to improve the function of ischemic and reperfused tissue
6284727, Apr 07 1993 Scios INC Prolonged delivery of peptides
6287295, Jul 25 1997 INTARCIA THERAPEUTICS, INC Osmotic delivery system, osmotic delivery system semimpermeable body assembly, and method for controlling delivery rate of beneficial agents from osmotic delivery systems
6329336, May 17 1999 Conjuchem, LLC Long lasting insulinotropic peptides
6331311, Dec 20 1996 DURECT CORPORATION Injectable depot gel composition and method of preparing the composition
6372218, Nov 06 1986 The Texas A&M University System Interferon dosage form and method therefor
6372256, Mar 06 1995 Ethicon, Inc. Hydrogels containing absorbable polyoxaamides
6375978, Dec 22 1997 INTARCIA THERAPEUTICS, INC Rate controlling membranes for controlled drug delivery devices
6395282, Apr 16 1998 ROCHESTER, UNIVERSITY OF Immunogenic conjugates of Gram-negative bacterial autoinducer molecules
6395292, Feb 02 1996 INTARCIA THERAPEUTICS, INC Sustained delivery of an active agent using an implantable system
6402716, Feb 20 1998 LG Chemical Ltd. Syringe assembly
6403655, Mar 06 1995 Ethicon, Inc Method of preventing adhesions with absorbable polyoxaesters
6419952, Dec 17 1998 Encinal Pharmaceutical Investments, LLC Conversion of liquid filled gelatin capsules into controlled release systems by multiple coatings
6428517, May 10 1999 CARDIAC SCIENCE, INC ; Milestone Scientific, Inc Hand-piece for injection device with a retractable and rotating needle
6433144, Jan 12 1999 VIRAGEN, INC Compositions of highly-purified natural mixtures of type I Interferon derived from leukocytes and methods
6436091, Nov 16 1999 Microsolutions, Inc. Methods and implantable devices and systems for long term delivery of a pharmaceutical agent
6447522, Sep 30 1998 C. R. Bard, Inc. Implant delivery system
6451974, Mar 17 1999 Novo Nordisk A S Method of acylating peptides and novel acylating agents
6458385, Mar 06 1995 Ethicon, Inc. Hydrogels containing absorbable polyoxaamides
6458387, Oct 18 1999 Baxter International Inc; BAXTER HEALTHCARE SA A CORPORATION OF SWITZERLAND Sustained release microspheres
6458924, Aug 30 1996 Novo Nordisk A/S Derivatives of GLP-1 analogs
6461605, Nov 02 1995 Merck Sharp & Dohme Corp Continuous low-dose cytokine infusion therapy
6464688, Feb 15 2000 Microsolutions, Inc. Osmotic pump delivery system with flexible drug compartment
6468961, Dec 20 1996 DURECT CORPORATION Gel composition and methods
6471688, Feb 15 2000 Microsolutions, Inc. Osmotic pump drug delivery systems and methods
6472512, Jul 21 1998 Human Genome Sciences, INC Keratinocyte derived interferon
6478768, Aug 08 1997 Gaplast GmbH Implant syringe
6485706, Jun 04 1999 PATENT PROTECTION LEAGUE LLC Formulations comprising dehydrated particles of pharma-ceutical agents and process for preparing the same
6495164, May 25 2000 Alkermes Pharma Ireland Limited Preparation of injectable suspensions having improved injectability
6506724, Jun 01 1999 AstraZeneca Pharmaceuticals LP Use of exendins and agonists thereof for the treatment of gestational diabetes mellitus
6508808, Dec 21 1999 INTARCIA THERAPEUTICS, INC Valve for osmotic devices
6514500, Oct 15 1999 Conjuchem, LLC Long lasting synthetic glucagon like peptide {GLP-!}
6514517, Jun 20 2001 Ethicon, Inc Antimicrobial coatings for medical devices
6524305, Jul 25 1997 INTARCIA THERAPEUTICS, INC Osmotic delivery system flow modulator apparatus and method
6528093, Dec 07 1992 Takeda Pharmaceutical Company, Limited Sustained-release preparation
6528486, Jul 12 1999 ZP HOLDING SPV K S Peptide agonists of GLP-1 activity
6541021, Mar 18 1999 DURECT CORPORATION Devices and methods for pain management
6544239, Oct 16 1998 ICU MEDICAL SALES, INC Releasable locking needle assembly with optional release accessory therefor
6544252, Dec 31 1998 INTARCIA THERAPEUTICS, INC Osmotic delivery system having space efficient piston
6547250, Aug 21 2000 WESTPORT POWER INC Seal assembly with two sealing mechanisms for providing static and dynamic sealing
6551613, Sep 08 1998 Encinal Pharmaceutical Investments, LLC Dosage form comprising therapeutic formulation
6569420, May 04 1998 Genentech, Inc. Human interferon-ε: a type I interferon
6572890, Jan 13 2000 OSMOTICA KERESKEDELMI ÉS SZOLGÁLTATÓ KFT Osmotic device containing venlafaxine and an anti-psychotic agent
6579851, Mar 14 2000 Amylin Pharmaceuticals, Inc Effects of glucagon-like peptide-1 (7-36) on antro-pyloro-duodenal motility
6589157, May 18 2000 Integrated Implant Systems, L.L.C. Drive mechanism for medical instrument
6592508, Dec 18 1995 INTEGRATED IMPLANT SYSTEMS, L L C Fiberoptic-guided interstitial seed manual applicator and seed cartridge
6592887, Nov 11 1996 LTS Lohmann Therapie-Systeme AG Water soluble film for oral administration with instant wettability
6593295, May 17 1999 Conjuchem, LLC Long lasting insulinotropic peptides
6607529, Jun 19 1995 VIDAMED, INC Electrosurgical device
6626863, Nov 22 2000 NUSAF, LLC Safety syringe
6635268, Feb 02 1996 INTARCIA THERAPEUTICS, INC Sustained delivery of an active agent using an implantable system
6645192, Sep 30 1998 Eli Lilly and Company Pellet implant system for immediate and delayed release of antiparasitic drug
6667061, May 25 2000 Alkermes Pharma Ireland Limited Preparation of injectable suspensions having improved injectability
6670368, Apr 06 1999 AstraZeneca AB Pyrimidine compounds with pharmaceutical activity
6673767, Dec 20 1996 DURECT CORPORATION Gel composition and methods
6682522, Dec 21 1999 INTARCIA THERAPEUTICS, INC Valve for osmotic devices
6703225, Jan 12 1999 Sumitomo Pharmaceuticals Company, Limited Interferon-α
6703359, Feb 13 1998 AstraZeneca Pharmaceuticals LP Inotropic and diuretic effects of exendin and GLP-1
6706689, May 19 2000 AstraZeneca Pharmaceuticals LP Treatment of acute coronary syndrome with GLP-1
6709671, Nov 11 1996 LTS Lohmann Therapie-Systeme AG Water soluble film for oral administration with instant wettability
6720407, Aug 28 1998 Eli Lilly and Company Method for administering insulinotropic peptides
6730328, Oct 16 1996 DURECT CORPORATION Stable protein and nucleic acid formulations using non-aqueous, anhydrous, aprotic, hydrophobic, non-polar vehicles with low reactivity
6767887, Jun 05 1997 Roche Diagnostics GmbH Exendin analogues, processes for their preparation and medicaments containing them
6821949, Oct 15 1999 Conjuchem, LLC Long lasting synthetic glucagon-like peptide (GLP-1)
6833256, Jun 22 1999 University of Maryland Interferon tau mutants and methods for making them
6835194, Mar 18 1999 DURECT CORPORATION Implantable devices and methods for treatment of pain by delivery of fentanyl and fentanyl congeners
6840931, Jul 25 1997 INTARCIA THERAPEUTICS, INC Osmotic delivery system flow modulator apparatus and method
6849708, May 05 1986 The General Hospital Corporation Insulinotropic hormone and uses thereof
6849714, May 17 1999 Conjuchem, LLC Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components
6858576, Aug 08 1996 AstraZeneca Pharmaceuticals LP Methods for regulating gastrointestinal motility
6872700, Jan 14 1999 AstraZeneca Pharmaceuticals LP Methods for glucagon suppression
6875748, Apr 21 2000 Vical Incorporated Compositions and methods for in vivo delivery of polynucleotide-based therapeutics
6887470, Sep 10 1999 Conjuchem, LLC Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components
6887849, Oct 15 1999 Conjuchem, LLC Long lasting synthetic glucagon-like peptide {GLP-1}
6899887, Dec 29 1997 INTARCIA THERAPEUTICS, INC Osmotic delivery system with membrane plug retention mechanism
6899898, Dec 21 2000 Alrise Biosystems GmbH Induced phase transition method for the production of microparticles containing hydrophobic active agents
6902744, Jan 14 1999 AstraZeneca Pharmaceuticals LP Exendin agonist formulations and methods of administration thereof
6903186, Dec 07 1998 IPSEN PHARMA S A S Analogues of GLP-1
6913767, Oct 25 1993 Genentech, Inc. Compositions for microencapsulation of antigens for use as vaccines
6923800, Jul 25 1997 INTARCIA THERAPEUTICS, INC Osmotic delivery system, osmotic delivery system semipermeable body assembly, and method for controlling delivery rate of beneficial agents from osmotic delivery systems
6924264, Apr 30 1999 AstraZeneca Pharmaceuticals LP Modified exendins and exendin agonists
6939556, Jun 26 2002 INTARCIA THERAPEUTICS, INC Minimally compliant, volume efficient piston for osmotic drug delivery systems
6956026, Jan 07 1997 AstraZeneca Pharmaceuticals LP Use of exendins for the reduction of food intake
6960192, Apr 23 2002 INSULET CORPORATION Transcutaneous fluid delivery system
6969702, Nov 20 2002 NEWRON SWEDEN AB Compounds and methods for increasing neurogenesis
6976981, Dec 29 1997 INTARCIA THERAPEUTICS, INC Osmotic delivery system with membrane plug retention mechanism
6989366, Jan 07 1997 AstraZeneca Pharmaceuticals LP Exendins, exendin agonists, and methods for their use
6992065, Apr 19 2000 Genentech, Inc; DURECT CORPORATION Sustained release formulations
6997922, Dec 13 1998 INTARCIA THERAPEUTICS, INC Osmotic delivery system having space efficient piston
7008439, Sep 21 1990 ST JUDE MEDICAL PUERTO RICO LLC Device and method for sealing puncture wounds
7014636, Nov 21 2002 INTARCIA THERAPEUTICS, INC Osmotic delivery device having a two-way valve and a dynamically self-adjusting flow channel
7022674, Dec 16 1999 Eli Lilly and Company Polypeptide compositions with improved stability
7041646, Oct 05 2001 Bayer HealthCare LLC Methods of treating type 2 diabetes with peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists
7074423, Jun 17 2003 INTARCIA THERAPEUTICS, INC Osmotic delivery system with early zero order push power engine
7084243, Jun 16 2000 Eli Lilly and Company Glucagon-like peptide-1 analogs
7101567, May 29 1998 DAINIPPON SUMITOMO PHARMA CO , LTD Controlled release preparations having multi-layer structure
7101843, Aug 23 2001 Eli Lilly and Company Glucagon-like peptide-1 analogs
7112335, Jun 26 2002 INTARCIA THERAPEUTICS, INC Minimally compliant, volume-efficient piston for osmotic drug delivery systems
7115569, Jan 07 1997 Amylin Pharmaceuticals, Inc Exendins, exendin agonists, and methods for their use
7138375, Jan 07 1997 Amylin Pharmaceuticals, Inc Use of exendins and agonists thereof for lowering plasma lipid
7138486, May 05 1986 The General Hospital Corporation Insulinotropic hormone derivatives and uses thereof
7141547, Dec 21 2001 NOVOZYMES BIOPHARMA DK A S Albumin fusion proteins comprising GLP-1 polypeptides
7144863, Jun 01 2001 Eli Lilly and Company GLP-1 formulations with protracted time action
7153825, Dec 18 2001 Amylin Pharmaceuticals, Inc Methods for glucagon suppression using modified exendins
7157555, Aug 08 1997 AstraZeneca Pharmaceuticals LP Exendin agonist compounds
7163688, Jun 22 2001 INTARCIA THERAPEUTICS, INC Osmotic implant with membrane and membrane retention means
7163697, Jun 22 2001 Johns Hopkins University School of Medicine Biodegradable polymer compositions, compositions and uses related thereto
7199217, Dec 13 2000 Eli Lilly and Company Amidated glucagon-like peptide-1
7205409, Sep 04 2003 AbbVie Inc Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)
7207982, Mar 31 2003 INTARCIA THERAPEUTICS, INC Osmotic pump with means for dissipating internal pressure
7214206, Apr 03 2003 ENDO PHARMACEUTICALS SOLUTIONS INC Implanting device and method of using same
7241457, Sep 30 2003 INTARCIA THERAPEUTICS, INC Osmotically driven active agent delivery device providing an ascending release profile
7258869, Feb 08 1999 INTARCIA THERAPEUTICS, INC Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicle
7297761, Aug 08 1996 AstraZeneca Pharmaceuticals LP Pharmaceutical compositions containing exendins
7316680, Nov 21 2002 INTARCIA THERAPEUTICS, INC Osmotic delivery device having a two-way valve and a dynamically self-adjusting flow channel
7393827, Dec 30 2004 DIAKINE THERAPEUTICS, INC Pharmaceutical compositions and methods for restoring β-cell mass and function
7407499, Oct 31 2003 INTARCIA THERAPEUTICS, INC Osmotic pump with self-retaining, fast-start membrane plug
7442682, Oct 19 2004 Nitto Denko Corporation Transepithelial delivery of peptides with incretin hormone activities
7456254, Apr 15 2004 Alkermes Pharma Ireland Limited Polymer-based sustained release device
7459432, Sep 24 2001 Imperial Innovations Limited Modification of feeding behavior
7521423, Aug 08 1996 AstraZeneca Pharmaceuticals LP Exendin pharmaceutical compositions
7563871, Apr 15 2004 Alkermes Pharma Ireland Limited Polymer-based sustained release device
7589169, Feb 27 2002 PharmaIN Corporation Compositions for treatment with glucagon-like peptide, and methods of making and using the same
7604647, Oct 22 2004 Medical Instrument Development Laboratories, Inc.; MEDICAL INSTRUMENT DEVELOPMENT LABORATORIES, INC Ophthalmic cannula insertion tool and method
7612176, Apr 15 2004 Alkermes Pharma Ireland Limited Polymer-based sustained release device
7632256, Oct 24 2006 HR PHARMACEUTICALS, INC ; Wiesman Holdings, LLC; HR PHARMECEUTICALS, INC Catheter gripping device
7635463, Feb 27 2002 PharmaIN Corporation Compositions for delivery of therapeutics and other materials
7655254, Feb 03 2005 INTARCIA THERAPEUTICS, INC Implantable device for continuous delivery of interferon
7655257, Feb 02 1996 INTARCIA THERAPEUTICS, INC Sustained delivery of an active agent using an implantable system
7666835, Sep 07 2001 Imperial Innovations Limited; IMPERIAL INNOVATIONS LIMTIED Oxyntomodulin for preventing or treating excess weight
7682356, Aug 09 2006 INTARCIA THERAPEUTICS, INC Osmotic delivery systems and piston assemblies for use therein
7727519, Nov 03 2000 Intarcia Therapeutics, Inc. Method for treating hepatitis C virus with omega interferon
7731947, Nov 17 2003 INTARCIA THERAPEUTICS, INC Composition and dosage form comprising an interferon particle formulation and suspending vehicle
7736665, May 31 2002 FEDSON, INC Implantable polymeric device for sustained release of buprenorphine
7741269, Aug 08 1996 AstraZeneca Pharmaceuticals LP Exendins and exendin agonists for weight reduction and obesity
7766924, Jul 28 1999 Aesculap AG System for performing anastomosis
7790140, Feb 27 2002 PharmaIN Corporation Compositions for delivery of therapeutics and other materials, and methods of making and using the same
7825091, Jan 10 2003 Imperial Innovations Limited Modification of feeding behaviour
7829109, Nov 14 2001 DURECT CORPORATION Catheter injectable depot compositions and uses thereof
7833543, Jun 07 1995 DURECT CORPORATION High viscosity liquid controlled delivery system and medical or surgical device
7879028, Aug 09 2006 Intarcia Therapeutics, Inc. Osmotic delivery systems and piston assemblies for use therein
7879794, Mar 31 2005 AstraZeneca Pharmaceuticals LP Methods for controlling binge eating disorders
7919109, Feb 08 1999 Intarcia Therapeutics, Inc. Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles
7928065, Feb 13 1998 Amylin Pharmaceuticals, Inc. Methods of treatment using exendin peptides or GLP-1 peptides
7959938, Mar 15 2005 INTARCIA THERAPEUTICS, INC Polyoxaester suspending vehicles for use with implantable delivery systems
7964183, Nov 17 2003 Intarcia Therapeutics, Inc. Composition and dosage form comprising a particle formulation and suspending vehicle
8039432, Nov 09 2005 Conjuchem, LLC Method of treatment of diabetes and/or obesity with reduced nausea side effect
8048438, Feb 08 1999 Intarcia Therapeutics, Inc. Stable non- aqueous single phase viscous vehicles and formulations utilizing such vehicles
8052996, Feb 03 2005 INTARCIA THERAPEUTICS, INC Two-piece, internal-channel osmotic delivery system flow modulator
8058233, Jan 10 2002 Imperial Innovations Limited Modification of feeding behavior using PYY and GLP-1
8101576, Dec 13 2006 Imperial Innovations Limited Compounds and their effects on feeding behaviour
8114430, Mar 15 2005 Intarcia Therapeutics, Inc. Polyoxaester suspending vehicles for use with implantable delivery systems
8114437, Feb 03 2005 INTARCIA THERAPEUTICS, INC Solvent/polymer solutions as suspension vehicles
8158150, Feb 03 2005 Intarcia Therapeutics, Inc. Two-piece, internal-channel osmotic delivery system flow modulator
8173150, Feb 08 1999 Intarcia Therapeutics, Inc. Stable non-aqueous single phase viscous vehicles and formulations utlizing such vehicles
8202836, Mar 09 2005 Imperial Innovations Limited Modified PYY (3-36) peptides and their effects on feeding behavior
8206745, Feb 03 2005 Intarcia Therapeutics, Inc. Solvent/polymer solutions as suspension vehicles
8211467, Feb 03 2005 Intarcia Therapeutics, Inc. Osmotic drug delivery devices containing suspension formulations comprising particles having active agents and nonaqueous single-phase vehicles
8217001, Sep 24 2001 Oregon Health and Science University Modification of feeding behavior
8231859, Feb 27 2002 PharmaIN Corporation Compositions for delivery of therapeutics and other materials
8251946, Aug 24 2000 Cardiac Science Corporation Method for constructing an instrument with a two-part plunger for subcutaneous implantation
8257682, Feb 27 2002 PharmaIN Corporation Compositions for delivery of therapeutics and other materials
8257691, Nov 17 2003 Intarcia Therapeutics, Inc. Composition and dosage form comprising a particle formulation and suspending vehicle
8262667, Feb 23 2007 HOLMED, LLC Multi-diameter implant forceps
8263545, Aug 17 2006 AstraZeneca Pharmaceuticals LP GIP analog and hybrid polypeptides with selectable properties
8263736, Jul 03 2006 Imperial Innovations Limited Compounds and their effects on feeding behaviour
8268341, Feb 08 1999 Intarcia Therapeutics, Inc. Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles
8273365, Feb 03 2005 Intarcia Therapeutics, Inc. Two-piece, internal-channel osmotic delivery system flow modulator
8273713, Dec 14 2000 AstraZeneca Pharmaceuticals LP Methods of treating obesity using PYY[3-36]
8277776, Feb 27 2002 PharmaIN Corporation Compositions for delivery of therapeutics and other materials
8278267, Mar 31 2005 Amylin Pharmaceuticals, LLC Method of modifying food preference comprising administering amylin or amylin agonist
8288338, Aug 08 1996 Amylin Pharmaceuticals, LLC Exendin and exendin agonists for eating disorders
8298561, Sep 28 2009 INTARCIA THERAPEUTICS, INC Rapid establishment and/or termination of substantial steady-state drug delivery
8299025, Feb 03 2005 INTARCIA THERAPEUTICS, INC Suspension formulations of insulinotropic peptides and uses thereof
8343140, Feb 13 2008 INTARCIA THERAPEUTICS, INC Devices, formulations, and methods for delivery of multiple beneficial agents
8367095, Feb 03 2005 Intarcia Therapeutics, Inc. Two-piece, internal-channel osmotic delivery system flow modulator
8372424, Feb 08 1999 Intarcia Therapeutics, Inc. Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles
8398967, Dec 19 2002 INTARCIA THERAPEUTICS, INC Particle formulations for use in pharmaceutical compositions
8440226, Feb 03 2005 Intarcia Therapeutics, Inc. Solvent/polymer solutions as suspension vehicles
8454552, Aug 24 2000 Cardiac Science Corporation Method for constructing an instrument with a covered bore for subcutaneous implantation
8460694, Feb 03 2005 Intarcia Therapeutics, Inc. Solvent/polymer solutions as suspension vehicles
8470353, Feb 03 2005 Intarcia Therapeutics, Inc. Two-piece, internal-channel osmotic delivery system flow modulator
8722037, Mar 19 2004 MERCK SHARP & DOHME B V X-ray visible drug delivery device
8747412, Feb 14 2011 ENGAGE MEDICAL HOLDINGS, LLC System and method for bone anchor removal
8801700, Aug 09 2006 Intarcia Therapeutics, Inc. Osmotic delivery systems and piston assemblies for use therein
8815802, Dec 16 2009 Novo Nordisk A S GLP-1 analogues and derivatives
8865202, Nov 11 1996 LTS Lohmann Therapie-Systeme AG Water soluble film for oral administration with instant wettability
8888745, Jan 24 2005 MERCK SHARP & DOHME B V Applicator for inserting an implant
8926595, Feb 13 2008 Intarcia Therapeutics, Inc. Devices, formulations, and methods for delivery of multiple beneficial agents
8940316, Feb 03 2005 INTARCIA THERAPEUTICS, INC Osmotic delivery comprising an insulinotropic peptide and uses thereof
8992961, Feb 08 1999 Intarcia Therapeutics, Inc. Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles
8992962, Feb 03 2005 Intarcia Therapeutics Inc. Two-piece, internal-channel osmotic delivery system flow modulator
9044209, Nov 25 2008 SOLACE THERAPEUTICS, INC Method of removing an inflated implant
9078900, Sep 30 2008 BRAEBURN PHARMACEUTICALS, INC Implantable device for the delivery of risperidone and methods of use thereof
9095553, Feb 03 2005 Intarcia Therapeutics Inc. Solvent/polymer solutions as suspension vehicles
9526763, Feb 03 2005 Intarcia Therapeutics Inc. Solvent/polymer solutions as suspension vehicles
9539200, Feb 03 2005 Intarcia Therapeutics Inc. Two-piece, internal-channel osmotic delivery system flow modulator
9572889, Feb 13 2008 Intarcia Therapeutics, Inc. Devices, formulations, and methods for delivery of multiple beneficial agents
9682127, Feb 03 2005 Intarcia Therapeutics, Inc. Osmotic delivery device comprising an insulinotropic peptide and uses thereof
9889085, Sep 30 2014 Intarcia Therapeutics, Inc. Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
20010012511,
20010021377,
20010021822,
20010022974,
20010026793,
20010027311,
20010031790,
20010031940,
20010036472,
20010040326,
20020001631,
20020004481,
20020012818,
20020034532,
20020037309,
20020048600,
20020077599,
20020098180,
20020136848,
20020137666,
20020141985,
20020197185,
20020197235,
20030007992,
20030032947,
20030040699,
20030044467,
20030045454,
20030059376,
20030059471,
20030060425,
20030078618,
20030097121,
20030104063,
20030108608,
20030108609,
20030113380,
20030114837,
20030118660,
20030135153,
20030138403,
20030138491,
20030157178,
20030170289,
20030180364,
20030186858,
20030191099,
20030211974,
20030215515,
20030220617,
20030233101,
20040001689,
20040001889,
20040002442,
20040022859,
20040024068,
20040024069,
20040029784,
20040039376,
20040047888,
20040097906,
20040101557,
20040102762,
20040115236,
20040142867,
20040142902,
20040151753,
20040157951,
20040198654,
20040199140,
20040209801,
20040215133,
20040224903,
20040225113,
20040243106,
20040265273,
20040266683,
20040266692,
20050004557,
20050008661,
20050009742,
20050010196,
20050010942,
20050070883,
20050070927,
20050079200,
20050079202,
20050095284,
20050101943,
20050106214,
20050112188,
20050118206,
20050118221,
20050131386,
20050131389,
20050143749,
20050175701,
20050201980,
20050215475,
20050216087,
20050266087,
20050271702,
20050276856,
20050281879,
20060013879,
20060014678,
20060030526,
20060069029,
20060073182,
20060084604,
20060084922,
20060094652,
20060094693,
20060106399,
20060141040,
20060142234,
20060160736,
20060178304,
20060193918,
20060216242,
20060224145,
20060233841,
20060246138,
20060251618,
20060263433,
20060264890,
20060280795,
20060293232,
20070027105,
20070141102,
20070149011,
20070166352,
20070207958,
20070248572,
20070281024,
20080020016,
20080038316,
20080064636,
20080065090,
20080091176,
20080110515,
20080112994,
20080200383,
20080207512,
20080226625,
20080226689,
20080260838,
20080260840,
20080269725,
20080312157,
20090012463,
20090022727,
20090036364,
20090042781,
20090074734,
20090087408,
20090156474,
20090163447,
20090186817,
20090202481,
20090202608,
20090209460,
20090210019,
20090215694,
20090247463,
20090254143,
20090286723,
20090312246,
20100092566,
20100094252,
20100105627,
20100144621,
20100185184,
20100297209,
20100298807,
20100298840,
20100331868,
20110076317,
20110091527,
20110104111,
20110152181,
20110152182,
20110160708,
20110166554,
20110264077,
20110306549,
20120178687,
20120208755,
20120303045,
20130030417,
20130034210,
20130052237,
20130296661,
20130324977,
20140058409,
20140058425,
20140121741,
20140163057,
20140236162,
20140257272,
20140324067,
20140378900,
20150001118,
20150057227,
20150111818,
20150133791,
20150231062,
20150231256,
20150297509,
20150359553,
20160022582,
20160030337,
20160354115,
20160354305,
20170056476,
20170079906,
20170119854,
20170119855,
20170181964,
20170252409,
20170319470,
20170319662,
20170348392,
20170368145,
20180009871,
D430671, May 10 1999 SHUTE, CHRISTOPHER W Obstetrical forceps
D565179, Jun 16 2005 PENTAX Corporation; Shinichiro, Kubo Bone implant
D789539, Jul 09 2015 Spinal Surgical Strategies, LLC Fusion cage
D816843, Jun 07 2017 ALEVIO, LLC Orthopedic implant
D835783, Jun 02 2016 Intarcia Therapeutics, Inc. Implant placement guide
D840030, Jun 02 2016 INTARCIA THERAPEUTICS INC Implant placement guide
DE635692,
EP79405,
EP254394,
EP295411,
EP304107,
EP368339,
EP373867,
EP379147,
EP431942,
EP486959,
EP497575,
EP521586,
EP596161,
EP627231,
EP631794,
EP729747,
EP767689,
EP771817,
EP841359,
EP1046399,
EP1084703,
EP1300129,
EP1300173,
EP1323450,
EP1600187,
EP2020990,
EP2133073,
FR2616665,
FR640907,
GB1049104,
GB1518683,
GB2138298,
GB2501400,
JP11100353,
JP1997509346,
JP2006213727,
JP2124814,
JP7196479,
JP9241153,
NL8901004,
NL9000948,
NL9100160,
NZ592113,
TW200634060,
WO13663,
WO29206,
WO38652,
WO39280,
WO40273,
WO41548,
WO45790,
WO54745,
WO66138,
WO67728,
WO1043528,
WO1051041,
WO128631,
WO168168,
WO178683,
WO2028366,
WO2036072,
WO2043800,
WO2045752,
WO2067895,
WO2069983,
WO2085428,
WO247716,
WO276344,
WO3000230,
WO3007981,
WO3011892,
WO3024357,
WO3024503,
WO3030923,
WO3041684,
WO3041757,
WO3053400,
WO3072113,
WO3072133,
WO4002565,
WO4046338,
WO4052336,
WO4056338,
WO4089335,
WO5048930,
WO5048952,
WO5102293,
WO6017772,
WO6023526,
WO6081279,
WO6083761,
WO6084139,
WO6086727,
WO6101815,
WO6111169,
WO7024700,
WO7056681,
WO7075534,
WO7084460,
WO7133778,
WO7140416,
WO8021133,
WO8061355,
WO8133908,
WO8134425,
WO9109927,
WO1989003678,
WO1990013285,
WO1990013361,
WO1990013780,
WO1992019241,
WO1994010982,
WO1995013799,
WO1996036317,
WO1996040049,
WO1997031943,
WO1997041837,
WO1997044039,
WO1998007412,
WO1998030231,
WO199813091,
WO1999012549,
WO2000059476,
WO2000066087,
WO2001019345,
WO2001028525,
WO2003020245,
WO2003066585,
WO2004026106,
WO2004034975,
WO2004035754,
WO2004035762,
WO2004036186,
WO2004089458,
WO2004103342,
WO2005102293,
WO2005110425,
WO2006077242,
WO2006077250,
WO2006131730,
WO2007082889,
WO2008041245,
WO2008086086,
WO2009143285,
WO2010045169,
WO2013004983,
WO2013184235,
WO9107160,
WO93008832,
WO9306819,
WO9306821,
WO9309763,
WO9323083,
WO9409743,
WO9421262,
WO9501167,
WO9509006,
WO9509007,
WO9534285,
WO96001134,
WO96003116,
WO9639142,
WO9640049,
WO9640139,
WO9640355,
WO9715289,
WO9715296,
WO9728181,
WO9746204,
WO9747339,
WO9800152,
WO9800157,
WO9800158,
WO9802169,
WO98027962,
WO98030231,
WO9813092,
WO9816250,
WO9817315,
WO9820930,
WO9827960,
WO9827963,
WO9832463,
WO9842317,
WO9847487,
WO9851282,
WO9858698,
WO99004768,
WO99025728,
WO99033446,
WO9903453,
WO99040788,
WO99044659,
WO9904767,
WO99062501,
WO99064061,
WO9916419,
WO9929306,
WO9933449,
WO9939700,
///////
Executed onAssignorAssigneeConveyanceFrameReelDoc
Oct 23 2018Intarcia Therapeutics, Inc.(assignment on the face of the patent)
Oct 04 2019INTARCIA THERAPEUTICS, INC MIDCAP FINANCIAL TRUST, AS AGENTSECURITY INTEREST SEE DOCUMENT FOR DETAILS 0506730020 pdf
Oct 04 2019INTARCIA IRELAND LIMITEDMIDCAP FINANCIAL TRUST, AS AGENTSECURITY INTEREST SEE DOCUMENT FOR DETAILS 0506730020 pdf
Oct 04 2019INTARCIA THERAPEUTICS, INC BAUPOST PRIVATE INVESTMENTS BVIV-3, L L C , AS COLLATERAL AGENTSECURITY INTEREST SEE DOCUMENT FOR DETAILS 0508010267 pdf
Jan 17 2020BAUPOST PRIVATE INVESTMENTS BVIV-3, L L C AS COLLATERAL AGENTINTARCIA THERAPEUTICS, INC RELEASE BY SECURED PARTY SEE DOCUMENT FOR DETAILS 0517390453 pdf
Apr 15 2020MIDCAP FINANCIAL TRUST, AS AGENTINTARCIA THERAPEUTICS, INC RELEASE BY SECURED PARTY SEE DOCUMENT FOR DETAILS 0524330001 pdf
Apr 15 2020MIDCAP FINANCIAL TRUST, AS AGENTINTARCIA IRELAND LIMITEDRELEASE BY SECURED PARTY SEE DOCUMENT FOR DETAILS 0524330001 pdf
n/a
Date Maintenance Fee Events


n/a
Date Maintenance Schedule